Log in to your Inderes Free account to see all free content on this page.
AcouSort
14.6 SEK -3.63%Be the first to follow this company
AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.
Revenue
5.53M
EBIT %
-316.27 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
ACOU
Daily low / high price
14.1 / 15.55
SEK
Market cap
218.04M SEK
Turnover
37.52K SEK
Volume
2.6K
Financial calendar
Interim report
27.11.2024
Annual report
26.02.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Avanza Pension | 10.7 % | 10.7 % |
Thomas Laurell | 7.4 % | 7.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
AcouSort enters into collaboration with University College Dublin
AcouSort to attend ISCT Europe to expand its network in the cell therapy space
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio